Organization · Venture Capital
ATP (Apple Tree Partners)
Apple Tree Partners (ATP) is a life sciences venture capital firm based in New York, specializing in the creation and investment in biotechnology companies. Founded in 1999, ATP focuses on innovative therapeutics for various diseases and supports companies from seed stage through IPO.
Overview
What ATP (Apple Tree Partners) does
What ATP (Apple Tree Partners) is
Apple Tree Partners (ATP) is a life sciences venture capital firm based in New York, specializing in the creation and investment in biotechnology companies. Founded in 1999, ATP focuses on innovative therapeutics for various diseases and supports companies from seed stage through IPO.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 1999
- Approximate age
- About 27 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find ATP (Apple Tree Partners) elsewhere
Open the official website or a supported primary organization account.
Capability profile
ATP (Apple Tree Partners) as a funder
Investment thesis
ATP creates and invests in life-sciences companies from the earliest scientific stage through public-company scale, focusing on pre-IP ideas, spinouts, seed-stage investing, and IPO support.
Focus narrative
ATP invests in life sciences companies, supporting them from seed stage through IPO and beyond. Their investment strategy includes working with scientists on pre-IP ideas and facilitating spinouts from existing company pipelines.
Value beyond capital
ATP provides flexible capital, strategic insight, operational resources, and access to venture partners and entrepreneurs-in-residence. Their in-house incubator, ATP R&D Labs, launched in 2022, generates foundational science for portfolio companies.
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B · Series C · Ipo
- Regions
- Global · North America · Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 30
- Recorded notable exits
- Akero Therapeutics, Chinook Therapeutics, Corvidia Therapeutics, Syntimmune, Tendyne, and Tusker Medical, plus 1 more
Portfolio context
Notable portfolio companies include: Aethon Therapeutics: KRAS-G12C synthetic neoantigen immunotherapy company. Akero Therapeutics: Clinical-stage metabolic disease company announced for acquisition by Novo Nordisk for up to $5.2B. Ascidian Therapeutics: RNA exon editing company advancing ACDN-01 for Stargardt disease. Aulos Bioscience: Immuno-oncology company developing imneskibart / AU-007. Deep Apple Therapeutics: Structure-based and deep-learning-enabled drug discovery company. Galvanize Therapeutics: Pulsed electric field platform for solid tumors and chronic bronchitis. Marengo Therapeutics: Precision T-cell immunology and dual T-cell agonist therapeutics. Nereid Therapeutics: Biotech company with ATP board/scientific leadership. Red Queen Therapeutics: Antiviral therapeutics company launched by ATP. Replicate Bioscience: Self-replicating RNA vaccines and therapeutics company funded by ATP.
Common questions
What to know about ATP (Apple Tree Partners)
Upseed classifies ATP (Apple Tree Partners) under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.